newsfilter
← Latest News
Business Wire·

PolarityTE Announces Diabetic Foot Ulcer Trial Met Primary and Secondary Endpoint

Reports Peer-Reviewed Publication of Interim Results from Diabetic Foot Ulcer Trial in International Wound Journal PolarityTE, Inc. (NASDAQ:PTE) today announced preliminary topline data demonstrating that a multi-center randomized controlled trial ev